変形性関節症の鎮痛剤の世界市場レポート2024-2030

QY Research > レポート一覧 > 薬品及びサプリメント > 変形性関節症の鎮痛剤の世界市場レポート2024-2030

英文タイトル： Global Osteoarthritis Pain Drugs Market Insights, Forecast to 2030

レポートID：42162
発表時期：2024-04-07
訪問回数：164
ページ数：128
レポート形式：PDF
レポート言語：英語、日本語
グラフ数：155
レポートカテゴリ：薬品及びサプリメント

販売価格（消費税別）

個人版
詳細
マルチユーザー版
詳細
企業版
詳細

価格表記: USDを日本円(税抜)に換算，本日の銀行送金レート: 1USD=161円。
※米ドル表示価格+10％消費税。

英語版

日本語版

英語と日本語版

価格表記: USDを日本円(税抜)に換算，本日の銀行送金レート: 1USD=161円。
※米ドル表示価格+10％消費税。

お見積

サンプルお申込み

お問い合わせ

今すぐ購入

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合，注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。但し、日本語版が必要な場合は、受注後8～10営業日となります。お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

概要

本報告書は、変形性関節症の鎮痛剤の世界市場、容量、生産量、収益、価格の概要を紹介します。2019~2023年の歴史的な市場収益/売上データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。本レポートはメーカー、地域、製品の種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、製品タイプとアプリケーション/端末業界別に変形性関節症の鎮痛剤市場を分類しています。

本レポートでは世界の変形性関節症の鎮痛剤市場の主な参加者として、企業概要、販売数量、収益、価格、粗利益率、ポートフォリオ、地理的位置、重要な発展を次のパラメータに基づいて紹介します。本研究に含まれる主な企業は：Pfizer、Bayer、SK Chemicals、GSK、Sanofi、Crystal Genomics、Johnson & Johnson、Sino Biopharmaceutical、Haohai Biological、Zhejiang Chengyi Pharmaceutical、Freda、Bright Future、Jingfeng Pharmaceutical、Chugai Pharmaceutical、Mikasa Seiyaku、Taisho Pharmaceutical、Seikagaku Corporation、GlaxoSmithKline、Eli Lilly、Novartis、Horizon Pharma、Abbott、Mylan、Daiichi Sankyo、TEVA、Almatica Pharma、Astellas Pharma、Tide Pharmaceutical、Iroko Pharmaceuticals、Hengrui Pharmaceutical

レポートは変形性関節症の鎮痛剤の主要生産者を調査し、主要地域や国の消費状況も提供します。変形性関節症の鎮痛剤の今後の市場の可能性のハイライト、およびこの市場をさまざまなセグメントおよびサブセグメントに予測するための主要な地域/国の焦点。アメリカとカナダ、中国、アジア、ヨーロッパ、中東、アフリカ、ラテンアメリカ、およびその他の国の国別データと市場価値分析。

2019年から2030年までのタイプ別および用途別、売上高、収益、価格別のセグメントデータを分析します。

タイプ別市場セグメント：
Oral
Injection
External

用途別の市場セグメント：
Medical Care
Personal Care

本レポートの詳細内容
本レポートは、世界の変形性関節症の鎮痛剤市場の現状と将来展望を包括的に分析し、グローバルの主要地域における開発動向の綿密な調査を通じて、読者に包括的な市場分析を提示するものであります。市場の全体像を把握するために、プレイヤー、地域、製品タイプ、最終産業を網羅した多角的な分析を提供しています。さらに、世界市場のトッププレイヤーを特定し、プロファイルを作成するとともに、製品タイプや用途/最終産業に基づいて変形性関節症の鎮痛剤市場を細分化しています。この分類と応用により、市場の構造とダイナミクスをより深く理解することができ、情報に基づいた意思決定と戦略立案が可能になります。

一. 生産面では、2019年から2024年まで、そして2030年までの予測として、メーカー別、地域別（地域レベル、国レベル）の変形性関節症の鎮痛剤生産量、成長率、市場シェアを調査している。

二. 消費面では、変形性関節症の鎮痛剤の売上高を地域別（地域レベル・国レベル）、企業別、種類別、用途別に焦点を当てています。2019年から2024年まで、2030年までの予測。

三.主要メーカーの変形性関節症の鎮痛剤売上高、収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界の変形性関節症の鎮痛剤市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。

四.本変形性関節症の鎮痛剤のレポートでは関係者が市場の競争状況を包括的に理解し、事業戦略や市場戦略を的確に立てるのに役立つ洞察を提供することを目的としています。売上高、成長動向、生産技術、用途、エンドユーザー産業の市場規模に関する詳細な評価と予測を提供し、意思決定者に強力なデータサポートを提供します。

章の概要

第1章：変形性関節症の鎮痛剤のレポート範囲、各市場セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメントのエグゼクティブサマリー（タイプ別およびアプリケーション別など）を紹介します。市場の現状と、短期から中期、および長期的な進化の可能性を高度に見ることができます。（2019～2030）
第2章：変形性関節症の鎮痛剤の世界と主要生産者（地域／国）の生産／アウトプット。各生産者の生産量と今後6年間の発展可能性を定量的に分析しています。（2019～2030）
第3章：世界、地域、国レベルにおける変形性関節症の鎮痛剤の売上（消費）、収益。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界の各国の市場発展、将来の発展の見通し、市場空間を紹介します。（2019～2030）
第4章変形性関節症の鎮痛剤メーカーの競争状況、価格、売上高、収益、市場シェアと業界ランキング、最新の開発計画、合併、買収情報などの詳細分析。（2019～2024）
第5章：変形性関節症の鎮痛剤の各市場セグメントの売上高、収益、平均価格、および開発可能性をカバーした種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第6章：アプリケーション別の様々な市場セグメントの分析を提供し、各市場セグメントの売上高、収益、平均価格、発展の可能性をカバーし、読者が異なる下流市場でのブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第7章：北米（米国・カナダ）：タイプ別、用途別、国別、セグメント別の売上高、収益。（2019～2030）
第8章：ヨーロッパ：タイプ別、用途別、国別、セグメント別の売上高と収益。（2019～2030）
第9章：中国：タイプ別、アプリケーション別、セグメント別の売上高、収益。（2019～2030）
第10章：アジア（中国を除く）：タイプ別、用途別、地域別、セグメント別の売上高、収益。（2019～2030）
第11章：中東、アフリカ、中南米：タイプ別、用途別、国別、セグメント別の売上高、収益。（2019～2030）
第12章：変形性関節症の鎮痛剤の主要メーカーの概要を提供し、製品の説明と仕様、変形性関節症の鎮痛剤の売上高、収益、価格、粗利益率、最近の発展など、市場の主要企業の基本的な状況を詳細に紹介します。（2019～2024）
第13章：産業チェーン、販売チャネル、主要原材料、販売代理店および顧客の分析。
第14章：変形性関節症の鎮痛剤の市場動態、市場の最新の動向、市場の推進要因と制約要因、業界内のメーカーが直面する課題とリスク、業界内の関連政策の分析を紹介します。
第15章：レポートの要点と結論。

概要

The main role of osteoarthritis pain drugs is to relieve pain, and cannot slow the progress of osteoarthritis, osteoarthritis in the use of two kinds of painkillers.

The global Osteoarthritis Pain Drugs market is projected to grow from US$ 10420 million in 2024 to US$ 14530 million by 2030, at a Compound Annual Growth Rate (CAGR) of 5.7% during the forecast period.
The major players in global Methylcyclohexane market include Pfizer, Johnson & Johnson, GlaxoSmithKline, etc. The top 3 players occupy about 45% shares of the global market. North America and Europe are main markets, they occupy about 70% of the global market. Oral is the main type, with a share over 50%. Personal Care is the main application, which holds a share about 90%.
Report Covers:
This report presents an overview of global market for Osteoarthritis Pain Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Osteoarthritis Pain Drugs, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Osteoarthritis Pain Drugs, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Osteoarthritis Pain Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Osteoarthritis Pain Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Osteoarthritis Pain Drugs sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Pfizer
Bayer
SK Chemicals
GSK
Sanofi
Crystal Genomics
Johnson & Johnson
Sino Biopharmaceutical
Haohai Biological
Zhejiang Chengyi Pharmaceutical
Freda
Bright Future
Jingfeng Pharmaceutical
Chugai Pharmaceutical
Mikasa Seiyaku
Taisho Pharmaceutical
Seikagaku Corporation
GlaxoSmithKline
Eli Lilly
Novartis
Horizon Pharma
Abbott
Mylan
Daiichi Sankyo
TEVA
Almatica Pharma
Astellas Pharma
Tide Pharmaceutical
Iroko Pharmaceuticals
Hengrui Pharmaceutical

Segment by Type
Oral
Injection
External

Segment by Application
Medical Care
Personal Care

Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Osteoarthritis Pain Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Osteoarthritis Pain Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Osteoarthritis Pain Drugs sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.

総目録

1 Study Coverage
1.1 Osteoarthritis Pain Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Osteoarthritis Pain Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Oral
1.2.3 Injection
1.2.4 External
1.3 Market by Application
1.3.1 Global Osteoarthritis Pain Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Medical Care
1.3.3 Personal Care
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered

2 Executive Summary
2.1 Global Osteoarthritis Pain Drugs Sales Estimates and Forecasts 2019-2030
2.2 Global Osteoarthritis Pain Drugs Revenue by Region
2.2.1 Global Osteoarthritis Pain Drugs Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Osteoarthritis Pain Drugs Revenue by Region (2019-2024)
2.2.3 Global Osteoarthritis Pain Drugs Revenue by Region (2025-2030)
2.2.4 Global Osteoarthritis Pain Drugs Revenue Market Share by Region (2019-2030)
2.3 Global Osteoarthritis Pain Drugs Sales Estimates and Forecasts 2019-2030
2.4 Global Osteoarthritis Pain Drugs Sales by Region
2.4.1 Global Osteoarthritis Pain Drugs Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Osteoarthritis Pain Drugs Sales by Region (2019-2024)
2.4.3 Global Osteoarthritis Pain Drugs Sales by Region (2025-2030)
2.4.4 Global Osteoarthritis Pain Drugs Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America

3 Competition by Manufactures
3.1 Global Osteoarthritis Pain Drugs Sales by Manufacturers
3.1.1 Global Osteoarthritis Pain Drugs Sales by Manufacturers (2019-2024)
3.1.2 Global Osteoarthritis Pain Drugs Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Osteoarthritis Pain Drugs in 2023
3.2 Global Osteoarthritis Pain Drugs Revenue by Manufacturers
3.2.1 Global Osteoarthritis Pain Drugs Revenue by Manufacturers (2019-2024)
3.2.2 Global Osteoarthritis Pain Drugs Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Osteoarthritis Pain Drugs Revenue in 2023
3.3 Global Key Players of Osteoarthritis Pain Drugs, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Osteoarthritis Pain Drugs Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Osteoarthritis Pain Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Osteoarthritis Pain Drugs, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Osteoarthritis Pain Drugs, Product Offered and Application
3.8 Global Key Manufacturers of Osteoarthritis Pain Drugs, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global Osteoarthritis Pain Drugs Sales by Type
4.1.1 Global Osteoarthritis Pain Drugs Historical Sales by Type (2019-2024)
4.1.2 Global Osteoarthritis Pain Drugs Forecasted Sales by Type (2025-2030)
4.1.3 Global Osteoarthritis Pain Drugs Sales Market Share by Type (2019-2030)
4.2 Global Osteoarthritis Pain Drugs Revenue by Type
4.2.1 Global Osteoarthritis Pain Drugs Historical Revenue by Type (2019-2024)
4.2.2 Global Osteoarthritis Pain Drugs Forecasted Revenue by Type (2025-2030)
4.2.3 Global Osteoarthritis Pain Drugs Revenue Market Share by Type (2019-2030)
4.3 Global Osteoarthritis Pain Drugs Price by Type
4.3.1 Global Osteoarthritis Pain Drugs Price by Type (2019-2024)
4.3.2 Global Osteoarthritis Pain Drugs Price Forecast by Type (2025-2030)

5 Market Size by Application
5.1 Global Osteoarthritis Pain Drugs Sales by Application
5.1.1 Global Osteoarthritis Pain Drugs Historical Sales by Application (2019-2024)
5.1.2 Global Osteoarthritis Pain Drugs Forecasted Sales by Application (2025-2030)
5.1.3 Global Osteoarthritis Pain Drugs Sales Market Share by Application (2019-2030)
5.2 Global Osteoarthritis Pain Drugs Revenue by Application
5.2.1 Global Osteoarthritis Pain Drugs Historical Revenue by Application (2019-2024)
5.2.2 Global Osteoarthritis Pain Drugs Forecasted Revenue by Application (2025-2030)
5.2.3 Global Osteoarthritis Pain Drugs Revenue Market Share by Application (2019-2030)
5.3 Global Osteoarthritis Pain Drugs Price by Application
5.3.1 Global Osteoarthritis Pain Drugs Price by Application (2019-2024)
5.3.2 Global Osteoarthritis Pain Drugs Price Forecast by Application (2025-2030)

6 US & Canada
6.1 US & Canada Osteoarthritis Pain Drugs Market Size by Type
6.1.1 US & Canada Osteoarthritis Pain Drugs Sales by Type (2019-2030)
6.1.2 US & Canada Osteoarthritis Pain Drugs Revenue by Type (2019-2030)
6.2 US & Canada Osteoarthritis Pain Drugs Market Size by Application
6.2.1 US & Canada Osteoarthritis Pain Drugs Sales by Application (2019-2030)
6.2.2 US & Canada Osteoarthritis Pain Drugs Revenue by Application (2019-2030)
6.3 US & Canada Osteoarthritis Pain Drugs Market Size by Country
6.3.1 US & Canada Osteoarthritis Pain Drugs Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Osteoarthritis Pain Drugs Sales by Country (2019-2030)
6.3.3 US & Canada Osteoarthritis Pain Drugs Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada

7 Europe
7.1 Europe Osteoarthritis Pain Drugs Market Size by Type
7.1.1 Europe Osteoarthritis Pain Drugs Sales by Type (2019-2030)
7.1.2 Europe Osteoarthritis Pain Drugs Revenue by Type (2019-2030)
7.2 Europe Osteoarthritis Pain Drugs Market Size by Application
7.2.1 Europe Osteoarthritis Pain Drugs Sales by Application (2019-2030)
7.2.2 Europe Osteoarthritis Pain Drugs Revenue by Application (2019-2030)
7.3 Europe Osteoarthritis Pain Drugs Market Size by Country
7.3.1 Europe Osteoarthritis Pain Drugs Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Osteoarthritis Pain Drugs Sales by Country (2019-2030)
7.3.3 Europe Osteoarthritis Pain Drugs Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia

8 China
8.1 China Osteoarthritis Pain Drugs Market Size
8.1.1 China Osteoarthritis Pain Drugs Sales (2019-2030)
8.1.2 China Osteoarthritis Pain Drugs Revenue (2019-2030)
8.2 China Osteoarthritis Pain Drugs Market Size by Application
8.2.1 China Osteoarthritis Pain Drugs Sales by Application (2019-2030)
8.2.2 China Osteoarthritis Pain Drugs Revenue by Application (2019-2030)

9 Asia (excluding China)
9.1 Asia Osteoarthritis Pain Drugs Market Size by Type
9.1.1 Asia Osteoarthritis Pain Drugs Sales by Type (2019-2030)
9.1.2 Asia Osteoarthritis Pain Drugs Revenue by Type (2019-2030)
9.2 Asia Osteoarthritis Pain Drugs Market Size by Application
9.2.1 Asia Osteoarthritis Pain Drugs Sales by Application (2019-2030)
9.2.2 Asia Osteoarthritis Pain Drugs Revenue by Application (2019-2030)
9.3 Asia Osteoarthritis Pain Drugs Sales by Region
9.3.1 Asia Osteoarthritis Pain Drugs Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Osteoarthritis Pain Drugs Revenue by Region (2019-2030)
9.3.3 Asia Osteoarthritis Pain Drugs Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India

10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Osteoarthritis Pain Drugs Market Size by Type
10.1.1 Middle East, Africa and Latin America Osteoarthritis Pain Drugs Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Osteoarthritis Pain Drugs Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Osteoarthritis Pain Drugs Market Size by Application
10.2.1 Middle East, Africa and Latin America Osteoarthritis Pain Drugs Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Osteoarthritis Pain Drugs Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Osteoarthritis Pain Drugs Sales by Country
10.3.1 Middle East, Africa and Latin America Osteoarthritis Pain Drugs Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Osteoarthritis Pain Drugs Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Osteoarthritis Pain Drugs Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries

11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Company Information
11.1.2 Pfizer Overview
11.1.3 Pfizer Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Pfizer Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Pfizer Recent Developments
11.2 Bayer
11.2.1 Bayer Company Information
11.2.2 Bayer Overview
11.2.3 Bayer Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Bayer Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Bayer Recent Developments
11.3 SK Chemicals
11.3.1 SK Chemicals Company Information
11.3.2 SK Chemicals Overview
11.3.3 SK Chemicals Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 SK Chemicals Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 SK Chemicals Recent Developments
11.4 GSK
11.4.1 GSK Company Information
11.4.2 GSK Overview
11.4.3 GSK Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 GSK Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 GSK Recent Developments
11.5 Sanofi
11.5.1 Sanofi Company Information
11.5.2 Sanofi Overview
11.5.3 Sanofi Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 Sanofi Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Sanofi Recent Developments
11.6 Crystal Genomics
11.6.1 Crystal Genomics Company Information
11.6.2 Crystal Genomics Overview
11.6.3 Crystal Genomics Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 Crystal Genomics Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Crystal Genomics Recent Developments
11.7 Johnson & Johnson
11.7.1 Johnson & Johnson Company Information
11.7.2 Johnson & Johnson Overview
11.7.3 Johnson & Johnson Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 Johnson & Johnson Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Johnson & Johnson Recent Developments
11.8 Sino Biopharmaceutical
11.8.1 Sino Biopharmaceutical Company Information
11.8.2 Sino Biopharmaceutical Overview
11.8.3 Sino Biopharmaceutical Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
11.8.4 Sino Biopharmaceutical Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Sino Biopharmaceutical Recent Developments
11.9 Haohai Biological
11.9.1 Haohai Biological Company Information
11.9.2 Haohai Biological Overview
11.9.3 Haohai Biological Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
11.9.4 Haohai Biological Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Haohai Biological Recent Developments
11.10 Zhejiang Chengyi Pharmaceutical
11.10.1 Zhejiang Chengyi Pharmaceutical Company Information
11.10.2 Zhejiang Chengyi Pharmaceutical Overview
11.10.3 Zhejiang Chengyi Pharmaceutical Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
11.10.4 Zhejiang Chengyi Pharmaceutical Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Zhejiang Chengyi Pharmaceutical Recent Developments
11.11 Freda
11.11.1 Freda Company Information
11.11.2 Freda Overview
11.11.3 Freda Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
11.11.4 Freda Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Freda Recent Developments
11.12 Bright Future
11.12.1 Bright Future Company Information
11.12.2 Bright Future Overview
11.12.3 Bright Future Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
11.12.4 Bright Future Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Bright Future Recent Developments
11.13 Jingfeng Pharmaceutical
11.13.1 Jingfeng Pharmaceutical Company Information
11.13.2 Jingfeng Pharmaceutical Overview
11.13.3 Jingfeng Pharmaceutical Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
11.13.4 Jingfeng Pharmaceutical Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Jingfeng Pharmaceutical Recent Developments
11.14 Chugai Pharmaceutical
11.14.1 Chugai Pharmaceutical Company Information
11.14.2 Chugai Pharmaceutical Overview
11.14.3 Chugai Pharmaceutical Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
11.14.4 Chugai Pharmaceutical Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Chugai Pharmaceutical Recent Developments
11.15 Mikasa Seiyaku
11.15.1 Mikasa Seiyaku Company Information
11.15.2 Mikasa Seiyaku Overview
11.15.3 Mikasa Seiyaku Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
11.15.4 Mikasa Seiyaku Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Mikasa Seiyaku Recent Developments
11.16 Taisho Pharmaceutical
11.16.1 Taisho Pharmaceutical Company Information
11.16.2 Taisho Pharmaceutical Overview
11.16.3 Taisho Pharmaceutical Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
11.16.4 Taisho Pharmaceutical Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Taisho Pharmaceutical Recent Developments
11.17 Seikagaku Corporation
11.17.1 Seikagaku Corporation Company Information
11.17.2 Seikagaku Corporation Overview
11.17.3 Seikagaku Corporation Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
11.17.4 Seikagaku Corporation Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Seikagaku Corporation Recent Developments
11.18 GlaxoSmithKline
11.18.1 GlaxoSmithKline Company Information
11.18.2 GlaxoSmithKline Overview
11.18.3 GlaxoSmithKline Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
11.18.4 GlaxoSmithKline Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 GlaxoSmithKline Recent Developments
11.19 Eli Lilly
11.19.1 Eli Lilly Company Information
11.19.2 Eli Lilly Overview
11.19.3 Eli Lilly Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
11.19.4 Eli Lilly Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.19.5 Eli Lilly Recent Developments
11.20 Novartis
11.20.1 Novartis Company Information
11.20.2 Novartis Overview
11.20.3 Novartis Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
11.20.4 Novartis Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.20.5 Novartis Recent Developments
11.21 Horizon Pharma
11.21.1 Horizon Pharma Company Information
11.21.2 Horizon Pharma Overview
11.21.3 Horizon Pharma Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
11.21.4 Horizon Pharma Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.21.5 Horizon Pharma Recent Developments
11.22 Abbott
11.22.1 Abbott Company Information
11.22.2 Abbott Overview
11.22.3 Abbott Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
11.22.4 Abbott Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.22.5 Abbott Recent Developments
11.23 Mylan
11.23.1 Mylan Company Information
11.23.2 Mylan Overview
11.23.3 Mylan Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
11.23.4 Mylan Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.23.5 Mylan Recent Developments
11.24 Daiichi Sankyo
11.24.1 Daiichi Sankyo Company Information
11.24.2 Daiichi Sankyo Overview
11.24.3 Daiichi Sankyo Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
11.24.4 Daiichi Sankyo Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.24.5 Daiichi Sankyo Recent Developments
11.25 TEVA
11.25.1 TEVA Company Information
11.25.2 TEVA Overview
11.25.3 TEVA Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
11.25.4 TEVA Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.25.5 TEVA Recent Developments
11.26 Almatica Pharma
11.26.1 Almatica Pharma Company Information
11.26.2 Almatica Pharma Overview
11.26.3 Almatica Pharma Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
11.26.4 Almatica Pharma Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.26.5 Almatica Pharma Recent Developments
11.27 Astellas Pharma
11.27.1 Astellas Pharma Company Information
11.27.2 Astellas Pharma Overview
11.27.3 Astellas Pharma Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
11.27.4 Astellas Pharma Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.27.5 Astellas Pharma Recent Developments
11.28 Tide Pharmaceutical
11.28.1 Tide Pharmaceutical Company Information
11.28.2 Tide Pharmaceutical Overview
11.28.3 Tide Pharmaceutical Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
11.28.4 Tide Pharmaceutical Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.28.5 Tide Pharmaceutical Recent Developments
11.29 Iroko Pharmaceuticals
11.29.1 Iroko Pharmaceuticals Company Information
11.29.2 Iroko Pharmaceuticals Overview
11.29.3 Iroko Pharmaceuticals Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
11.29.4 Iroko Pharmaceuticals Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.29.5 Iroko Pharmaceuticals Recent Developments
11.30 Hengrui Pharmaceutical
11.30.1 Hengrui Pharmaceutical Company Information
11.30.2 Hengrui Pharmaceutical Overview
11.30.3 Hengrui Pharmaceutical Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
11.30.4 Hengrui Pharmaceutical Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.30.5 Hengrui Pharmaceutical Recent Developments

12 Industry Chain and Sales Channels Analysis
12.1 Osteoarthritis Pain Drugs Industry Chain Analysis
12.2 Osteoarthritis Pain Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Osteoarthritis Pain Drugs Production Mode & Process
12.4 Osteoarthritis Pain Drugs Sales and Marketing
12.4.1 Osteoarthritis Pain Drugs Sales Channels
12.4.2 Osteoarthritis Pain Drugs Distributors
12.5 Osteoarthritis Pain Drugs Customers

13 Market Dynamics
13.1 Osteoarthritis Pain Drugs Industry Trends
13.2 Osteoarthritis Pain Drugs Market Drivers
13.3 Osteoarthritis Pain Drugs Market Challenges
13.4 Osteoarthritis Pain Drugs Market Restraints

14 Key Findings in The Global Osteoarthritis Pain Drugs Study

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

表と図のリスト

List of Tables
    Table 1. Global Osteoarthritis Pain Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Table 2. Major Manufacturers of Oral
    Table 3. Major Manufacturers of Injection
    Table 4. Major Manufacturers of External
    Table 5. Global Osteoarthritis Pain Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Table 6. Global Osteoarthritis Pain Drugs Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 7. Global Osteoarthritis Pain Drugs Revenue by Region (2019-2024) & (US$ Million)
    Table 8. Global Osteoarthritis Pain Drugs Revenue by Region (2025-2030) & (US$ Million)
    Table 9. Global Osteoarthritis Pain Drugs Revenue Market Share by Region (2019-2024)
    Table 10. Global Osteoarthritis Pain Drugs Revenue Market Share by Region (2025-2030)
    Table 11. Global Osteoarthritis Pain Drugs Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 12. Global Osteoarthritis Pain Drugs Sales by Region (2019-2024) & (K Units)
    Table 13. Global Osteoarthritis Pain Drugs Sales by Region (2025-2030) & (K Units)
    Table 14. Global Osteoarthritis Pain Drugs Sales Market Share by Region (2019-2024)
    Table 15. Global Osteoarthritis Pain Drugs Sales Market Share by Region (2025-2030)
    Table 16. Global Osteoarthritis Pain Drugs Sales by Manufacturers (2019-2024) & (K Units)
    Table 17. Global Osteoarthritis Pain Drugs Sales Share by Manufacturers (2019-2024)
    Table 18. Global Osteoarthritis Pain Drugs Revenue by Manufacturers (2019-2024) & (US$ Million)
    Table 19. Global Osteoarthritis Pain Drugs Revenue Share by Manufacturers (2019-2024)
    Table 20. Global Key Players of Osteoarthritis Pain Drugs, Industry Ranking, 2022 VS 2023 VS 2024
    Table 21. Osteoarthritis Pain Drugs Price by Manufacturers 2019-2024 (USD/Unit)
    Table 22. Global Osteoarthritis Pain Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 23. Global Osteoarthritis Pain Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Osteoarthritis Pain Drugs as of 2023)
    Table 24. Global Key Manufacturers of Osteoarthritis Pain Drugs, Manufacturing Base Distribution and Headquarters
    Table 25. Global Key Manufacturers of Osteoarthritis Pain Drugs, Product Offered and Application
    Table 26. Global Key Manufacturers of Osteoarthritis Pain Drugs, Date of Enter into This Industry
    Table 27. Mergers & Acquisitions, Expansion Plans
    Table 28. Global Osteoarthritis Pain Drugs Sales by Type (2019-2024) & (K Units)
    Table 29. Global Osteoarthritis Pain Drugs Sales by Type (2025-2030) & (K Units)
    Table 30. Global Osteoarthritis Pain Drugs Sales Share by Type (2019-2024)
    Table 31. Global Osteoarthritis Pain Drugs Sales Share by Type (2025-2030)
    Table 32. Global Osteoarthritis Pain Drugs Revenue by Type (2019-2024) & (US$ Million)
    Table 33. Global Osteoarthritis Pain Drugs Revenue by Type (2025-2030) & (US$ Million)
    Table 34. Global Osteoarthritis Pain Drugs Revenue Share by Type (2019-2024)
    Table 35. Global Osteoarthritis Pain Drugs Revenue Share by Type (2025-2030)
    Table 36. Osteoarthritis Pain Drugs Price by Type (2019-2024) & (USD/Unit)
    Table 37. Global Osteoarthritis Pain Drugs Price Forecast by Type (2025-2030) & (USD/Unit)
    Table 38. Global Osteoarthritis Pain Drugs Sales by Application (2019-2024) & (K Units)
    Table 39. Global Osteoarthritis Pain Drugs Sales by Application (2025-2030) & (K Units)
    Table 40. Global Osteoarthritis Pain Drugs Sales Share by Application (2019-2024)
    Table 41. Global Osteoarthritis Pain Drugs Sales Share by Application (2025-2030)
    Table 42. Global Osteoarthritis Pain Drugs Revenue by Application (2019-2024) & (US$ Million)
    Table 43. Global Osteoarthritis Pain Drugs Revenue by Application (2025-2030) & (US$ Million)
    Table 44. Global Osteoarthritis Pain Drugs Revenue Share by Application (2019-2024)
    Table 45. Global Osteoarthritis Pain Drugs Revenue Share by Application (2025-2030)
    Table 46. Osteoarthritis Pain Drugs Price by Application (2019-2024) & (USD/Unit)
    Table 47. Global Osteoarthritis Pain Drugs Price Forecast by Application (2025-2030) & (USD/Unit)
    Table 48. US & Canada Osteoarthritis Pain Drugs Sales by Type (2019-2024) & (K Units)
    Table 49. US & Canada Osteoarthritis Pain Drugs Sales by Type (2025-2030) & (K Units)
    Table 50. US & Canada Osteoarthritis Pain Drugs Revenue by Type (2019-2024) & (US$ Million)
    Table 51. US & Canada Osteoarthritis Pain Drugs Revenue by Type (2025-2030) & (US$ Million)
    Table 52. US & Canada Osteoarthritis Pain Drugs Sales by Application (2019-2024) & (K Units)
    Table 53. US & Canada Osteoarthritis Pain Drugs Sales by Application (2025-2030) & (K Units)
    Table 54. US & Canada Osteoarthritis Pain Drugs Revenue by Application (2019-2024) & (US$ Million)
    Table 55. US & Canada Osteoarthritis Pain Drugs Revenue by Application (2025-2030) & (US$ Million)
    Table 56. US & Canada Osteoarthritis Pain Drugs Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 57. US & Canada Osteoarthritis Pain Drugs Revenue by Country (2019-2024) & (US$ Million)
    Table 58. US & Canada Osteoarthritis Pain Drugs Revenue by Country (2025-2030) & (US$ Million)
    Table 59. US & Canada Osteoarthritis Pain Drugs Sales by Country (2019-2024) & (K Units)
    Table 60. US & Canada Osteoarthritis Pain Drugs Sales by Country (2025-2030) & (K Units)
    Table 61. Europe Osteoarthritis Pain Drugs Sales by Type (2019-2024) & (K Units)
    Table 62. Europe Osteoarthritis Pain Drugs Sales by Type (2025-2030) & (K Units)
    Table 63. Europe Osteoarthritis Pain Drugs Revenue by Type (2019-2024) & (US$ Million)
    Table 64. Europe Osteoarthritis Pain Drugs Revenue by Type (2025-2030) & (US$ Million)
    Table 65. Europe Osteoarthritis Pain Drugs Sales by Application (2019-2024) & (K Units)
    Table 66. Europe Osteoarthritis Pain Drugs Sales by Application (2025-2030) & (K Units)
    Table 67. Europe Osteoarthritis Pain Drugs Revenue by Application (2019-2024) & (US$ Million)
    Table 68. Europe Osteoarthritis Pain Drugs Revenue by Application (2025-2030) & (US$ Million)
    Table 69. Europe Osteoarthritis Pain Drugs Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 70. Europe Osteoarthritis Pain Drugs Revenue by Country (2019-2024) & (US$ Million)
    Table 71. Europe Osteoarthritis Pain Drugs Revenue by Country (2025-2030) & (US$ Million)
    Table 72. Europe Osteoarthritis Pain Drugs Sales by Country (2019-2024) & (K Units)
    Table 73. Europe Osteoarthritis Pain Drugs Sales by Country (2025-2030) & (K Units)
    Table 74. China Osteoarthritis Pain Drugs Sales by Type (2019-2024) & (K Units)
    Table 75. China Osteoarthritis Pain Drugs Sales by Type (2025-2030) & (K Units)
    Table 76. China Osteoarthritis Pain Drugs Revenue by Type (2019-2024) & (US$ Million)
    Table 77. China Osteoarthritis Pain Drugs Revenue by Type (2025-2030) & (US$ Million)
    Table 78. China Osteoarthritis Pain Drugs Sales by Application (2019-2024) & (K Units)
    Table 79. China Osteoarthritis Pain Drugs Sales by Application (2025-2030) & (K Units)
    Table 80. China Osteoarthritis Pain Drugs Revenue by Application (2019-2024) & (US$ Million)
    Table 81. China Osteoarthritis Pain Drugs Revenue by Application (2025-2030) & (US$ Million)
    Table 82. Asia Osteoarthritis Pain Drugs Sales by Type (2019-2024) & (K Units)
    Table 83. Asia Osteoarthritis Pain Drugs Sales by Type (2025-2030) & (K Units)
    Table 84. Asia Osteoarthritis Pain Drugs Revenue by Type (2019-2024) & (US$ Million)
    Table 85. Asia Osteoarthritis Pain Drugs Revenue by Type (2025-2030) & (US$ Million)
    Table 86. Asia Osteoarthritis Pain Drugs Sales by Application (2019-2024) & (K Units)
    Table 87. Asia Osteoarthritis Pain Drugs Sales by Application (2025-2030) & (K Units)
    Table 88. Asia Osteoarthritis Pain Drugs Revenue by Application (2019-2024) & (US$ Million)
    Table 89. Asia Osteoarthritis Pain Drugs Revenue by Application (2025-2030) & (US$ Million)
    Table 90. Asia Osteoarthritis Pain Drugs Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 91. Asia Osteoarthritis Pain Drugs Revenue by Region (2019-2024) & (US$ Million)
    Table 92. Asia Osteoarthritis Pain Drugs Revenue by Region (2025-2030) & (US$ Million)
    Table 93. Asia Osteoarthritis Pain Drugs Sales by Region (2019-2024) & (K Units)
    Table 94. Asia Osteoarthritis Pain Drugs Sales by Region (2025-2030) & (K Units)
    Table 95. Middle East, Africa and Latin America Osteoarthritis Pain Drugs Sales by Type (2019-2024) & (K Units)
    Table 96. Middle East, Africa and Latin America Osteoarthritis Pain Drugs Sales by Type (2025-2030) & (K Units)
    Table 97. Middle East, Africa and Latin America Osteoarthritis Pain Drugs Revenue by Type (2019-2024) & (US$ Million)
    Table 98. Middle East, Africa and Latin America Osteoarthritis Pain Drugs Revenue by Type (2025-2030) & (US$ Million)
    Table 99. Middle East, Africa and Latin America Osteoarthritis Pain Drugs Sales by Application (2019-2024) & (K Units)
    Table 100. Middle East, Africa and Latin America Osteoarthritis Pain Drugs Sales by Application (2025-2030) & (K Units)
    Table 101. Middle East, Africa and Latin America Osteoarthritis Pain Drugs Revenue by Application (2019-2024) & (US$ Million)
    Table 102. Middle East, Africa and Latin America Osteoarthritis Pain Drugs Revenue by Application (2025-2030) & (US$ Million)
    Table 103. Middle East, Africa and Latin America Osteoarthritis Pain Drugs Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 104. Middle East, Africa and Latin America Osteoarthritis Pain Drugs Revenue by Country (2019-2024) & (US$ Million)
    Table 105. Middle East, Africa and Latin America Osteoarthritis Pain Drugs Revenue by Country (2025-2030) & (US$ Million)
    Table 106. Middle East, Africa and Latin America Osteoarthritis Pain Drugs Sales by Country (2019-2024) & (K Units)
    Table 107. Middle East, Africa and Latin America Osteoarthritis Pain Drugs Sales by Country (2025-2030) & (K Units)
    Table 108. Pfizer Company Information
    Table 109. Pfizer Description and Major Businesses
    Table 110. Pfizer Osteoarthritis Pain Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 111. Pfizer Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 112. Pfizer Recent Developments
    Table 113. Bayer Company Information
    Table 114. Bayer Description and Major Businesses
    Table 115. Bayer Osteoarthritis Pain Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 116. Bayer Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 117. Bayer Recent Developments
    Table 118. SK Chemicals Company Information
    Table 119. SK Chemicals Description and Major Businesses
    Table 120. SK Chemicals Osteoarthritis Pain Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 121. SK Chemicals Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 122. SK Chemicals Recent Developments
    Table 123. GSK Company Information
    Table 124. GSK Description and Major Businesses
    Table 125. GSK Osteoarthritis Pain Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 126. GSK Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 127. GSK Recent Developments
    Table 128. Sanofi Company Information
    Table 129. Sanofi Description and Major Businesses
    Table 130. Sanofi Osteoarthritis Pain Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 131. Sanofi Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 132. Sanofi Recent Developments
    Table 133. Crystal Genomics Company Information
    Table 134. Crystal Genomics Description and Major Businesses
    Table 135. Crystal Genomics Osteoarthritis Pain Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 136. Crystal Genomics Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 137. Crystal Genomics Recent Developments
    Table 138. Johnson & Johnson Company Information
    Table 139. Johnson & Johnson Description and Major Businesses
    Table 140. Johnson & Johnson Osteoarthritis Pain Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 141. Johnson & Johnson Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 142. Johnson & Johnson Recent Developments
    Table 143. Sino Biopharmaceutical Company Information
    Table 144. Sino Biopharmaceutical Description and Major Businesses
    Table 145. Sino Biopharmaceutical Osteoarthritis Pain Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 146. Sino Biopharmaceutical Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 147. Sino Biopharmaceutical Recent Developments
    Table 148. Haohai Biological Company Information
    Table 149. Haohai Biological Description and Major Businesses
    Table 150. Haohai Biological Osteoarthritis Pain Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 151. Haohai Biological Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 152. Haohai Biological Recent Developments
    Table 153. Zhejiang Chengyi Pharmaceutical Company Information
    Table 154. Zhejiang Chengyi Pharmaceutical Description and Major Businesses
    Table 155. Zhejiang Chengyi Pharmaceutical Osteoarthritis Pain Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 156. Zhejiang Chengyi Pharmaceutical Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 157. Zhejiang Chengyi Pharmaceutical Recent Developments
    Table 158. Freda Company Information
    Table 159. Freda Description and Major Businesses
    Table 160. Freda Osteoarthritis Pain Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 161. Freda Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 162. Freda Recent Developments
    Table 163. Bright Future Company Information
    Table 164. Bright Future Description and Major Businesses
    Table 165. Bright Future Osteoarthritis Pain Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 166. Bright Future Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 167. Bright Future Recent Developments
    Table 168. Jingfeng Pharmaceutical Company Information
    Table 169. Jingfeng Pharmaceutical Description and Major Businesses
    Table 170. Jingfeng Pharmaceutical Osteoarthritis Pain Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 171. Jingfeng Pharmaceutical Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 172. Jingfeng Pharmaceutical Recent Developments
    Table 173. Chugai Pharmaceutical Company Information
    Table 174. Chugai Pharmaceutical Description and Major Businesses
    Table 175. Chugai Pharmaceutical Osteoarthritis Pain Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 176. Chugai Pharmaceutical Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 177. Chugai Pharmaceutical Recent Developments
    Table 178. Mikasa Seiyaku Company Information
    Table 179. Mikasa Seiyaku Description and Major Businesses
    Table 180. Mikasa Seiyaku Osteoarthritis Pain Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 181. Mikasa Seiyaku Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 182. Mikasa Seiyaku Recent Developments
    Table 183. Taisho Pharmaceutical Company Information
    Table 184. Taisho Pharmaceutical Description and Major Businesses
    Table 185. Taisho Pharmaceutical Osteoarthritis Pain Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 186. Taisho Pharmaceutical Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 187. Taisho Pharmaceutical Recent Developments
    Table 188. Seikagaku Corporation Company Information
    Table 189. Seikagaku Corporation Description and Major Businesses
    Table 190. Seikagaku Corporation Osteoarthritis Pain Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 191. Seikagaku Corporation Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 192. Seikagaku Corporation Recent Developments
    Table 193. GlaxoSmithKline Company Information
    Table 194. GlaxoSmithKline Description and Major Businesses
    Table 195. GlaxoSmithKline Osteoarthritis Pain Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 196. GlaxoSmithKline Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 197. GlaxoSmithKline Recent Developments
    Table 198. Eli Lilly Company Information
    Table 199. Eli Lilly Description and Major Businesses
    Table 200. Eli Lilly Osteoarthritis Pain Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 201. Eli Lilly Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 202. Eli Lilly Recent Developments
    Table 203. Novartis Company Information
    Table 204. Novartis Description and Major Businesses
    Table 205. Novartis Osteoarthritis Pain Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 206. Novartis Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 207. Novartis Recent Developments
    Table 208. Horizon Pharma Company Information
    Table 209. Horizon Pharma Description and Major Businesses
    Table 210. Horizon Pharma Osteoarthritis Pain Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 211. Horizon Pharma Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 212. Horizon Pharma Recent Developments
    Table 213. Abbott Company Information
    Table 214. Abbott Description and Major Businesses
    Table 215. Abbott Osteoarthritis Pain Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 216. Abbott Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 217. Abbott Recent Developments
    Table 218. Mylan Company Information
    Table 219. Mylan Description and Major Businesses
    Table 220. Mylan Osteoarthritis Pain Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 221. Mylan Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 222. Mylan Recent Developments
    Table 223. Daiichi Sankyo Company Information
    Table 224. Daiichi Sankyo Description and Major Businesses
    Table 225. Daiichi Sankyo Osteoarthritis Pain Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 226. Daiichi Sankyo Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 227. Daiichi Sankyo Recent Developments
    Table 228. TEVA Company Information
    Table 229. TEVA Description and Major Businesses
    Table 230. TEVA Osteoarthritis Pain Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 231. TEVA Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 232. TEVA Recent Developments
    Table 233. Almatica Pharma Company Information
    Table 234. Almatica Pharma Description and Major Businesses
    Table 235. Almatica Pharma Osteoarthritis Pain Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 236. Almatica Pharma Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 237. Almatica Pharma Recent Developments
    Table 238. Astellas Pharma Company Information
    Table 239. Astellas Pharma Description and Major Businesses
    Table 240. Astellas Pharma Osteoarthritis Pain Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 241. Astellas Pharma Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 242. Astellas Pharma Recent Developments
    Table 243. Tide Pharmaceutical Company Information
    Table 244. Tide Pharmaceutical Description and Major Businesses
    Table 245. Tide Pharmaceutical Osteoarthritis Pain Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 246. Tide Pharmaceutical Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 247. Tide Pharmaceutical Recent Developments
    Table 248. Iroko Pharmaceuticals Company Information
    Table 249. Iroko Pharmaceuticals Description and Major Businesses
    Table 250. Iroko Pharmaceuticals Osteoarthritis Pain Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 251. Iroko Pharmaceuticals Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 252. Iroko Pharmaceuticals Recent Developments
    Table 253. Hengrui Pharmaceutical Company Information
    Table 254. Hengrui Pharmaceutical Description and Major Businesses
    Table 255. Hengrui Pharmaceutical Osteoarthritis Pain Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 256. Hengrui Pharmaceutical Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 257. Hengrui Pharmaceutical Recent Developments
    Table 258. Key Raw Materials Lists
    Table 259. Raw Materials Key Suppliers Lists
    Table 260. Osteoarthritis Pain Drugs Distributors List
    Table 261. Osteoarthritis Pain Drugs Customers List
    Table 262. Osteoarthritis Pain Drugs Market Trends
    Table 263. Osteoarthritis Pain Drugs Market Drivers
    Table 264. Osteoarthritis Pain Drugs Market Challenges
    Table 265. Osteoarthritis Pain Drugs Market Restraints
    Table 266. Research Programs/Design for This Report
    Table 267. Key Data Information from Secondary Sources
    Table 268. Key Data Information from Primary Sources
List of Figures
    Figure 1. Osteoarthritis Pain Drugs Product Picture
    Figure 2. Global Osteoarthritis Pain Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Osteoarthritis Pain Drugs Market Share by Type in 2023 & 2030
    Figure 4. Oral Product Picture
    Figure 5. Injection Product Picture
    Figure 6. External Product Picture
    Figure 7. Global Osteoarthritis Pain Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 8. Global Osteoarthritis Pain Drugs Market Share by Application in 2023 & 2030
    Figure 9. Medical Care
    Figure 10. Personal Care
    Figure 11. Osteoarthritis Pain Drugs Report Years Considered
    Figure 12. Global Osteoarthritis Pain Drugs Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 13. Global Osteoarthritis Pain Drugs Revenue 2019-2030 (US$ Million)
    Figure 14. Global Osteoarthritis Pain Drugs Revenue Market Share by Region in Percentage: 2023 Versus 2030
    Figure 15. Global Osteoarthritis Pain Drugs Revenue Market Share by Region (2019-2030)
    Figure 16. Global Osteoarthritis Pain Drugs Sales 2019-2030 ((K Units)
    Figure 17. Global Osteoarthritis Pain Drugs Sales Market Share by Region (2019-2030)
    Figure 18. US & Canada Osteoarthritis Pain Drugs Sales YoY (2019-2030) & (K Units)
    Figure 19. US & Canada Osteoarthritis Pain Drugs Revenue YoY (2019-2030) & (US$ Million)
    Figure 20. Europe Osteoarthritis Pain Drugs Sales YoY (2019-2030) & (K Units)
    Figure 21. Europe Osteoarthritis Pain Drugs Revenue YoY (2019-2030) & (US$ Million)
    Figure 22. China Osteoarthritis Pain Drugs Sales YoY (2019-2030) & (K Units)
    Figure 23. China Osteoarthritis Pain Drugs Revenue YoY (2019-2030) & (US$ Million)
    Figure 24. Asia (excluding China) Osteoarthritis Pain Drugs Sales YoY (2019-2030) & (K Units)
    Figure 25. Asia (excluding China) Osteoarthritis Pain Drugs Revenue YoY (2019-2030) & (US$ Million)
    Figure 26. Middle East, Africa and Latin America Osteoarthritis Pain Drugs Sales YoY (2019-2030) & (K Units)
    Figure 27. Middle East, Africa and Latin America Osteoarthritis Pain Drugs Revenue YoY (2019-2030) & (US$ Million)
    Figure 28. The Osteoarthritis Pain Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
    Figure 29. The Top 5 and 10 Largest Manufacturers of Osteoarthritis Pain Drugs in the World: Market Share by Osteoarthritis Pain Drugs Revenue in 2023
    Figure 30. Global Osteoarthritis Pain Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 31. Global Osteoarthritis Pain Drugs Sales Market Share by Type (2019-2030)
    Figure 32. Global Osteoarthritis Pain Drugs Revenue Market Share by Type (2019-2030)
    Figure 33. Global Osteoarthritis Pain Drugs Sales Market Share by Application (2019-2030)
    Figure 34. Global Osteoarthritis Pain Drugs Revenue Market Share by Application (2019-2030)
    Figure 35. US & Canada Osteoarthritis Pain Drugs Sales Market Share by Type (2019-2030)
    Figure 36. US & Canada Osteoarthritis Pain Drugs Revenue Market Share by Type (2019-2030)
    Figure 37. US & Canada Osteoarthritis Pain Drugs Sales Market Share by Application (2019-2030)
    Figure 38. US & Canada Osteoarthritis Pain Drugs Revenue Market Share by Application (2019-2030)
    Figure 39. US & Canada Osteoarthritis Pain Drugs Revenue Share by Country (2019-2030)
    Figure 40. US & Canada Osteoarthritis Pain Drugs Sales Share by Country (2019-2030)
    Figure 41. U.S. Osteoarthritis Pain Drugs Revenue (2019-2030) & (US$ Million)
    Figure 42. Canada Osteoarthritis Pain Drugs Revenue (2019-2030) & (US$ Million)
    Figure 43. Europe Osteoarthritis Pain Drugs Sales Market Share by Type (2019-2030)
    Figure 44. Europe Osteoarthritis Pain Drugs Revenue Market Share by Type (2019-2030)
    Figure 45. Europe Osteoarthritis Pain Drugs Sales Market Share by Application (2019-2030)
    Figure 46. Europe Osteoarthritis Pain Drugs Revenue Market Share by Application (2019-2030)
    Figure 47. Europe Osteoarthritis Pain Drugs Revenue Share by Country (2019-2030)
    Figure 48. Europe Osteoarthritis Pain Drugs Sales Share by Country (2019-2030)
    Figure 49. Germany Osteoarthritis Pain Drugs Revenue (2019-2030) & (US$ Million)
    Figure 50. France Osteoarthritis Pain Drugs Revenue (2019-2030) & (US$ Million)
    Figure 51. U.K. Osteoarthritis Pain Drugs Revenue (2019-2030) & (US$ Million)
    Figure 52. Italy Osteoarthritis Pain Drugs Revenue (2019-2030) & (US$ Million)
    Figure 53. Russia Osteoarthritis Pain Drugs Revenue (2019-2030) & (US$ Million)
    Figure 54. China Osteoarthritis Pain Drugs Sales Market Share by Type (2019-2030)
    Figure 55. China Osteoarthritis Pain Drugs Revenue Market Share by Type (2019-2030)
    Figure 56. China Osteoarthritis Pain Drugs Sales Market Share by Application (2019-2030)
    Figure 57. China Osteoarthritis Pain Drugs Revenue Market Share by Application (2019-2030)
    Figure 58. Asia Osteoarthritis Pain Drugs Sales Market Share by Type (2019-2030)
    Figure 59. Asia Osteoarthritis Pain Drugs Revenue Market Share by Type (2019-2030)
    Figure 60. Asia Osteoarthritis Pain Drugs Sales Market Share by Application (2019-2030)
    Figure 61. Asia Osteoarthritis Pain Drugs Revenue Market Share by Application (2019-2030)
    Figure 62. Asia Osteoarthritis Pain Drugs Revenue Share by Region (2019-2030)
    Figure 63. Asia Osteoarthritis Pain Drugs Sales Share by Region (2019-2030)
    Figure 64. Japan Osteoarthritis Pain Drugs Revenue (2019-2030) & (US$ Million)
    Figure 65. South Korea Osteoarthritis Pain Drugs Revenue (2019-2030) & (US$ Million)
    Figure 66. China Taiwan Osteoarthritis Pain Drugs Revenue (2019-2030) & (US$ Million)
    Figure 67. Southeast Asia Osteoarthritis Pain Drugs Revenue (2019-2030) & (US$ Million)
    Figure 68. India Osteoarthritis Pain Drugs Revenue (2019-2030) & (US$ Million)
    Figure 69. Middle East, Africa and Latin America Osteoarthritis Pain Drugs Sales Market Share by Type (2019-2030)
    Figure 70. Middle East, Africa and Latin America Osteoarthritis Pain Drugs Revenue Market Share by Type (2019-2030)
    Figure 71. Middle East, Africa and Latin America Osteoarthritis Pain Drugs Sales Market Share by Application (2019-2030)
    Figure 72. Middle East, Africa and Latin America Osteoarthritis Pain Drugs Revenue Market Share by Application (2019-2030)
    Figure 73. Middle East, Africa and Latin America Osteoarthritis Pain Drugs Revenue Share by Country (2019-2030)
    Figure 74. Middle East, Africa and Latin America Osteoarthritis Pain Drugs Sales Shar

以下、関連資料のご紹介